Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10297)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2020 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nennstiel S, Schlag C. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids. World J Gastroenterol 2020; 26(36): 5395-5407 [PMID: 33024392 DOI: 10.3748/wjg.v26.i36.5395] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i36/5395.htm |
| Number | Citing Articles |
| 1 |
Julius Krause, Friederike Brokmann, Christoph Rosenbaum, Werner Weitschies. The challenges of drug delivery to the esophagus and how to overcome them. Expert Opinion on Drug Delivery 2022; 19(2): 119 doi: 10.1080/17425247.2022.2033206
|
| 2 |
R Loi, M Ceulemans, L Wauters, T Vanuytsel. An update on Eosinophilic Esophagitis. Acta Gastro Enterologica Belgica 2024; 86(4): 533 doi: 10.51821/86.4.12001
|
| 3 |
Albert J Bredenoord, Evan S Dellon, Ikuo Hirano, Alfredo J Lucendo, Christoph Schlag, Xian Sun, Lila Glotfelty, Leda Mannent, Jennifer Maloney, Elizabeth Laws, Eric Mortensen, Arsalan Shabbir. Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study. Gut 2023; : gutjnl-2023-330220 doi: 10.1136/gutjnl-2023-330220
|
| 4 |
Evan S. Dellon, Alfredo J. Lucendo, Christoph Schlag, Alain M. Schoepfer, Gary W. Falk, Gina Eagle, James Nezamis, Gail M. Comer, Karol Knoop, Ikuo Hirano. Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for Eosinophilic Esophagitis: Randomized Controlled Trial. Clinical Gastroenterology and Hepatology 2022; 20(11): 2485 doi: 10.1016/j.cgh.2022.02.013
|
| 5 |
Kasper Bredal, Line Tegtmeier Frandsen, Jacob Holmen Terkelsen, Martin Hollænder Nielsen, Dorte Melgaard, Anne Lund Krarup. There is a long way from current clinical practice in Denmark compared to recent published English guideline on management of children with eosinophilic oesophagitis. BMC Pediatrics 2024; 24(1) doi: 10.1186/s12887-023-04483-3
|
| 6 |
Stephan Miehlke, Ulrike von Arnim, Christoph Schlag, Joachim Labenz, Ahmed Madisch. Therapie der eosinophilen Ösophagitis – Fortschritte und Perspektiven. Zeitschrift für Gastroenterologie 2021; 59(08): 869 doi: 10.1055/a-1429-4192
|
| 7 |
Stephan Miehlke, Ulrike von Arnim, Christoph Schlag, Joachim Labenz, Ahmed Madisch. Therapie der eosinophilen Ösophagitis - Fortschritte und Perspektiven. Laryngo-Rhino-Otologie 2023; 102(05): 339 doi: 10.1055/a-1861-7152
|
| 8 |
Ikuo Hirano, Evan S. Dellon, Sandeep K. Gupta, David A. Katzka, Margaret H. Collins, Abigail M. Wojtowicz, Brian Terreri, Wenwen Zhang, Mena Boules, Siddharth Bhatia, Nirav K. Desai. Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1–3 clinical trials. Alimentary Pharmacology & Therapeutics 2023; 57(10): 1117 doi: 10.1111/apt.17430
|
| 9 |
Annie D. Fuller, Adam L. Karami, Mohammad Faujul Kabir, Alena Klochkova, Jazmyne L. Jackson, Anbin Mu, Yinfei Tan, Andres J. Klein-Szanto, Kelly A. Whelan. Eosinophilic esophagitis-associated epithelial remodeling may limit esophageal carcinogenesis. Frontiers in Allergy 2023; 4 doi: 10.3389/falgy.2023.1086032
|
| 10 |
Nicole Hannan, Janet Schloss, Matthew J. Leach. Safety and efficacy of complementary medicines for eosinophilic gastrointestinal disorders in adults: A systematic review and exploration of candidate interventions. Advances in Integrative Medicine 2023; 10(3): 131 doi: 10.1016/j.aimed.2023.09.002
|
| 11 |
Ikuo Hirano, Evan S. Dellon, Sandeep K. Gupta, David A. Katzka, Margaret H. Collins, Abigail M. Wojtowicz, Brian Terreri, Wenwen Zhang, Mena Boules, Siddharth Bhatia, Nirav K. Desai. Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis – new data bring new questions. Authors' reply. Alimentary Pharmacology & Therapeutics 2023; 57(10): 1163 doi: 10.1111/apt.17476
|
| 12 |
Francisca Molina‐Jiménez, Lola Ugalde‐Triviño, Laura Arias‐González, Carlos Relaño‐Rupérez, Sergio Casabona, María Teresa Pérez‐Fernández, Verónica Martín‐Domínguez, Jennifer Fernández‐Pacheco, Emilio José Laserna‐Mendieta, Patricia Muñoz‐Hernández, Ángel Arias‐Arias, Ainara Cano, Javier Muñoz, Alfredo J. Lucendo, Cecilio Santander, Pedro Majano. Proteomic analysis of the esophageal epithelium reveals key features of eosinophilic esophagitis pathophysiology. Allergy 2023; 78(10): 2732 doi: 10.1111/all.15779
|
| 13 |
Dilawar Khokhar, Sahiti Marella, Gila Idelman, Joy W. Chang, Mirna Chehade, Simon P. Hogan. Eosinophilic esophagitis: Immune mechanisms and therapeutic targets. Clinical & Experimental Allergy 2022; 52(10): 1142 doi: 10.1111/cea.14196
|
| 14 |
Twan Sia, Evan Cunningham, Megan Miller, Rebecca Nitschelm, Riki Tanaka, Taylor Epstein, Kendall Garrett, Amy Huang, Daniel Pak, Ally Scheve, John Leung. Food elimination diet is a viable alternative therapy for eosinophilic esophagitis responsive to proton pump inhibitors. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02703-9
|